名医传世

中国1000万医护成长平台

Downloads
Revenue

Description

广东医群科技有限公司成立于2014年, “基于SaaS云端服务的医学岗位能力提升培训管理模式”由旗下品牌名医传世首创,已成为国内知名的“互联网+医学教育”平台。目前,已与国内100余家三甲医院6000余名专家合作,根据国家培训大纲要求建设培训课程体系,共拍摄制作7000余部视频课程,涵盖住院医师、专科医生、全科医生、(助理)全科医生、乡村医生、护理人员、技术人员、公共卫生人员等医疗卫生相关岗位不同层级的培训课程体系,是目前国内唯一拥有较为完整视频培训课程体系的平台。
现今“名医传世”已为全国9个省级行政区,近300个县/市/区级行政区,数千家医疗卫生机构,60万名卫生技术人员提供系统化、规范化、标准化、流程化的在线培训服务,同时为各级医疗卫生机构提供医学培训整体解决方案,致力于我国基层医疗技术能力和医疗质量水平的双提升!
Hide Show More...

In-Apps

100金币
€1.99
500金币
€9.99
1000金币
€24.99
2000金币
€49.99
3000金币
€79.99
5000金币
€119.99
名医传世个人VIP会员
€249.99
您将会花费¥1098充值1098学习币
€199.99

Screenshots

名医传世 FAQ

  • Is 名医传世 free?

    Yes, 名医传世 is free to download, however it contains in-app purchases or subscription offerings.

  • Is 名医传世 legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does 名医传世 cost?

    名医传世 has several in-app purchases/subscriptions, the average in-app price is €92.12.

  • What is 名医传世 revenue?

    To get estimated revenue of 名医传世 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Greece yet.
Ratings History

名医传世 Reviews

No Reviews in Greece
App doesn't have any reviews in Greece yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

名医传世 Competitors

Name
京东医生
医师服务
培训考核两不误,服务更贴心!
昭昭医考-全方位医学考试题库与学习助手
医师/考研/主治,医考宝藏,昭昭画图,更懂考试重点难点
人民好医生-三甲医院主任医师直播在线咨询
人民网·人民好医生
微医生
全国医生互联网执业平台
医路有伴-专业的医疗外科教学平台
医教管理
好医生-助力医护学习成长
权威医学继教和好医生公开课学习
住院医师规范化培训系统
云鹊医

名医传世 Installs

Last 30 days

名医传世 Revenue

Last 30 days

名医传世 Revenue and Downloads

Gain valuable insights into 名医传世 performance with our analytics.
Sign up now to access downloads, revenue, and more.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.